Tumor cell death was significantly higher in CD38 KO mice [25], and follow-up studies demonstrated that similar results can be obtained with pharmacological targeting of CD38 through the administration of the inhibitor K-rhein [76], which is a flavonoid frequently used as pharmacologic inhibitor of CD38 [22]. The gene discussed is CD38; the disease is neoplasm.